H2AX and cancer: Treatment with doxorubicin or carboplatin induced DNA damage, as evidenced by γ-H2AX expression, and triggered apoptosis, as shown by cleaved PARP and Caspase3, in low DDB2-expressing cancer cells (e.g., MDA-MB-231, SK-BR-3, MDA-MB-468).